Stockreport

Intellia Therapeutics Full Year 2023 Earnings: Revenues Disappoint [Yahoo! Finance]

Intellia Therapeutics, Inc.  (NTLA) 
Last intellia therapeutics, inc. earnings: 2/27 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.intelliatx.com/investor-overview
PDF Net loss: US$481.2m (loss widened by 1.5% from FY 2022). US$5.42 loss per share. All figures shown in the chart above are for the trailing 12 month (TTM) period I [Read more]